Thrombocytopenia Therapy
New findings from Kumamoto University, Department of Hematology in the area of thrombocytopenia therapy published
Published in Hospital Law Weekly, October 30th, 2008
Research findings, 'Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid,' are discussed in a new report. "Cepharanthine (CEP), a biscoclaurine alkaloid extracted from Stephania Cepharantha Hayata, has been used in Japan for treating patients with radiation-induced leucopenia or thrombocytopenia. We treated a patient with multiple myeloma (MM), who was not responding to preceding chemotherapy, who coincidently received therapy with CEP due to thrombocytopenia," scientists in Kumamoto, Japan report.
"Since the case showed a marked reduction of tumor load, direct anti-tumor effects of CEP to myeloma cells were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-10-30)
More Articles from Hospital Law Weekly
- Beazley Group Plc
Caymich Member Hospitals First to Benefit From Innovative Approach to Professional Liability Insurance - HealthLeaders-InterStudy
State Healthcare Reform Brings Growth to Springfield, Mass., Hospital Segment - Heart Attack
Study findings on heart attack are outlined in reports from G.A. Wellenius and colleagues - Life Sciences
Hospice Legacy makes grant for study of end-of-life care - Medicare and Medicaid
Childbirth Connection Report Reveals Serious Problems in Maternity Care Quality and Value - Minnesota Nurses Association
Delegates to Annual Convention of Minnesota Nurses Association Address Organization and Professional Issues - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
